Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
Alessandro Cucchetti, Matteo Serenari, Carlo Sposito, Stefano Di Sandro, Cristina Mosconi, Ilaria Vicentin, Enrico Garanzini, Vincenzo Mazzaferro, Luciano De Carlis, Rita Golfieri, Carlo Spreafico, Angelo Vanzulli, Vincenzo Buscemi, Matteo Ravaioli, Giorgio Ercolani, Antonio Daniele Pinna, Matteo Cescon
Topics & Concepts
MedicineHepatocellular carcinomaInternal medicineLiver transplantationContext (archaeology)Radiological weaponIncidence (geometry)Response Evaluation Criteria in Solid TumorsGastroenterologyProgressive diseaseOncologyDiseaseTransplantationSurgeryBiologyPaleontologyOpticsPhysicsHepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and OutcomesCholangiocarcinoma and Gallbladder Cancer Studies